107 related articles for article (PubMed ID: 27193726)
1. Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum.
Fuwa T; Suzuki J; Tanaka T; Inomata A; Honda Y; Kodama T
J Toxicol Sci; 2016; 41(3):329-37. PubMed ID: 27193726
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.
Shimshoni JA; Winkler I; Golan E; Nutt D
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):15-24. PubMed ID: 27650729
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Tada Y; Inomata A
J Appl Toxicol; 2017 Mar; 37(3):243-252. PubMed ID: 27291301
[TBL] [Abstract][Full Text] [Related]
4. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
[TBL] [Abstract][Full Text] [Related]
5. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of fructose and N-acetyl-L-cysteine against cytotoxicity induced by the psychoactive compounds N-methyl-5-(2-aminopropyl)benzofuran and 3,4-methylenedioxy-N-methamphetamine in isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Inomata A
J Appl Toxicol; 2018 Feb; 38(2):284-291. PubMed ID: 28949027
[TBL] [Abstract][Full Text] [Related]
7. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
[TBL] [Abstract][Full Text] [Related]
8. Acute Toxicity Associated With the Recreational Use of the Novel Psychoactive Benzofuran N-methyl-5-(2 aminopropyl)benzofuran.
Hofer KE; Faber K; Müller DM; Hauffe T; Wenger U; Kupferschmidt H; Rauber-Lüthy C
Ann Emerg Med; 2017 Jan; 69(1):79-82. PubMed ID: 27156124
[TBL] [Abstract][Full Text] [Related]
9. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
Miller DB; O'Callaghan JP
Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of novel psychoactive benzofurans.
Rickli A; Kopf S; Hoener MC; Liechti ME
Br J Pharmacol; 2015 Jul; 172(13):3412-25. PubMed ID: 25765500
[TBL] [Abstract][Full Text] [Related]
11. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
12. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
Stanley N; Salem A; Irvine RJ
Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
[TBL] [Abstract][Full Text] [Related]
13. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
Nash JF; Brodkin J
J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
Nair SG; Gudelsky GA
Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
[TBL] [Abstract][Full Text] [Related]
15. An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA.
Falk EM; Cook VJ; Nichols DE; Sprague JE
Pharmacol Biochem Behav; 2002 Jun; 72(3):617-22. PubMed ID: 12175458
[TBL] [Abstract][Full Text] [Related]
16. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
[TBL] [Abstract][Full Text] [Related]
17. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
Gramsbergen JB; Cumming P
Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
[TBL] [Abstract][Full Text] [Related]
18. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.
Riegert C; Wedekind F; Hamida SB; Rutz S; Rothmaier AK; Jones BC; Cassel JC; Jackisch R
Int J Neuropsychopharmacol; 2008 Sep; 11(6):743-63. PubMed ID: 18248690
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
Rodsiri R; Green AR; Marsden CA; Fone KC
J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
[TBL] [Abstract][Full Text] [Related]
20. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]